MORGAN HEBERT: Open Payments
NPI 1225896855 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $158 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 2 | $62 |
| Calliditas Therapeutics US Inc. | 2 | $54 |
| Amgen Inc. | 2 | $48 |
| Fresenius USA Marketing, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $34 |
| Aurinia Pharma U.S., Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
Products named: PURIFIED CORTROPHIN GEL, TARPEYO, TAVNEOS, VELPHORO, Kerendia, LUPKYNIS, JYNARQUE.
Industry payments across VA — which companies pay providers there.
